一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> iScience >>article
iScience

iScience

IF: 4.6
Download PDF

Tivantinib alleviates inflammatory diseases by directly targeting NLRP3.

Published:17 March 2023 DOI: 10.1016/j.isci.2023.106062 PMID: 36843841
Yi Huang , Yun Guo , Yan Zhou , Qian Huang , Yi Ru , Yingli Luo , Wen Xu

Abstract

NLRP3 inflammasome-mediated immune responses are involved in the pathogenesis of multiple inflammatory diseases, but few clinical drugs are identified that directly target the NLRP3 inflammasome to treat these diseases to date. Here, we show that the anticancer agent tivantinib is a selective inhibitor of NLRP3 and has a strong therapeutic effect on inflammasome-driven disease. Tivantinib specifically inhibits canonical and non-canonical NLRP3 inflammasome activation without affecting AIM2 and NLRC4 inflammasome activation. Mechanistically, Tivantinib inhibits NLRP3 inflammasome by directly blocking NLRP3 ATPase activity and subsequent inflammasome complex assembly. In?vivo, Tivantinib reduces IL-1β production in mouse models of lipopolysaccharide (LPS)-induced systemic inflammation, monosodium urate (MSU)-induced peritonitis and Con A-induced acute liver injury (ALI), and also has remarkable preventive and therapeutic effects on experimental autoimmune encephalomyelitis (EAE). In conclusion, our study identifies the anticancer drug tivantinib as a specific inhibitor of NLRP3 and provides a promising therapeutic agent for inflammasome-driven disease.

Substances (21)

Materials Related products
Procduct Name CAS Molecular Formula Supplier Price
SGX-523 1022150-57-7 C18H13N7S 170 suppliers $15.00-$4050.00
SGX-523 1022150-57-7 C18H13N7S 170 suppliers $15.00-$4050.00
SGX-523 1022150-57-7 C18H13N7S 170 suppliers $15.00-$4050.00
SGX-523 1022150-57-7 C18H13N7S 170 suppliers $15.00-$4050.00
3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-pyrrolidine-2,5-dione 905854-02-6 C23H19N3O2 153 suppliers $16.00-$8042.00
3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-pyrrolidine-2,5-dione 905854-02-6 C23H19N3O2 153 suppliers $16.00-$8042.00
3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-pyrrolidine-2,5-dione 905854-02-6 C23H19N3O2 153 suppliers $16.00-$8042.00
3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-pyrrolidine-2,5-dione 905854-02-6 C23H19N3O2 153 suppliers $16.00-$8042.00
NVP-BVU 972 1185763-69-2 C20H16N6 110 suppliers $19.00-$2500.00
NVP-BVU 972 1185763-69-2 C20H16N6 110 suppliers $19.00-$2500.00

Similar articles

IF:2.9

TLR4 Inhibitor TAK‐242 Protected Henoch–Schonlein Purpura Nephritis in Rats by Regulating Inflammatory Response and Immune Competence via NF‐ κB/NLRP3 Signalling

Clinical and Experimental Pharmacology and Physiology Yirong Liu, Qiong Wu,etc Published: 20 November 2024
IF:4.3

The Pharmacological Effect of Hemin in Inflammatory-Related Diseases: A Systematic Review

ACS Applied Electronic Materials Jo?o Estarreja, Gon?alo Caldeira,etc Published: 18 April 2024
IF:5.4

Protective effects and mechanism of puerarin targeting PI3K/Akt signal pathway on neurological diseases.

ACS Applied Energy Materials Qian Wang, Zi-Nuo Shen,etc Published: 24 October 2022
舟山市| 城口县| 泌阳县| 宜春市| 商河县| 扶余县| 防城港市| 仙桃市| 高平市| 西乌| 谢通门县| 龙口市| 改则县| 涟水县| 庄浪县| 阳泉市| 高安市| 广元市| 雅安市| 左贡县| 阿克陶县| 南平市| 肥城市| 南漳县| 宜宾县| 扶沟县| 蒙山县| 宁国市| 黑山县| 佳木斯市| 无锡市| 黎城县| 重庆市| 威信县| 舒城县| 天镇县| 吴堡县| 泗洪县| 岐山县| 敖汉旗| 定安县|